High-dose statins don't raise diabetes odds in low-risk patients

01/16/2013 | CardiovascularBusiness.com

A meta-analysis in the Journal of the American College of Cardiology found high-dose statin treatment may increase the risk of new onset diabetes in people with two or more risk factors for diabetes. However, those who were at low risk of diabetes did not show an increased risk of diabetes despite receiving high statin doses, researchers said.

View Full Article in:

CardiovascularBusiness.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park